EdiGene Inc., headquartered in Beijing, with operational subsidiaries in Guangzhou, China and Cambridge, USA and which d...
Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange tra...
Accuray Asia Limited, a subsidiary of Accuray Incorporated, and CNNC High Energy Equipment (Tianjin) Co., Ltd, a subsidi...
CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for ca...
I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the developm...
GeneQuantum Healthcare of Suzhou and MITRO Biotech of Nanjing recently signed the "Strategic Cooperation Agreement ...
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...
China's leading one-stop healthcare ecosystem platform Ping An Health Medical Technology Company Limited has announced t...
BioDuro, a leading global life sciences contract research and development organization, and Advent International, o...
Biotech Company, Amgen has announced the National Medical Products Administration (NMPA) approval of a new ind...
Led by the Shanghai Branch of PICC Health Insurance and the Shanghai MediTrust Health as well as supported by Pfiz...
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading prov...
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...
Beijing-based Immunochina Pharmaceuticals recently announced the closing of its $20.4 million Series C financing. This ...
iKang Healthcare Group, Inc., a major provider in China’s fast growing private preventive healthcare services mark...
CHINA AID 2019, hosted by Shanghai Intex Exhibition Co., Ltd., is taking place from Wednesday 11th to Friday 1...
AOTI Inc. has entered into a major strategic relationship with a leading Chinese medical company, Nanning Xinzizhu Tradi...
Luye Pharma has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights...
